Details
Stereochemistry | ACHIRAL |
Molecular Formula | Na.2H2O.H2O4P |
Molecular Weight | 156.0076 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.O.[Na+].OP(O)([O-])=O
InChI
InChIKey=VBJGJHBYWREJQD-UHFFFAOYSA-M
InChI=1S/Na.H3O4P.2H2O/c;1-5(2,3)4;;/h;(H3,1,2,3,4);2*1H2/q+1;;;/p-1
Phosphoric acid, also known as orthophosphoric acid, is used in dentistry and orthodontics to clean and roughen the surfaces of teeth where dental appliances or fillings will be placed. In addition, this acid is a part of product ProcalAmine, which is indicated for peripheral administration in adults to preserve body protein and improve nitrogen balance in well-nourished, mildly catabolic patients who require short-term parenteral nutrition. In combination with dextrose (glucose) and levulose (fructose), phosphoric acid relieves nausea due to upset stomach from intestinal flu, stomach flu, and food or drink indiscretions. In addition, homeopathic product, Brain power contains also phosphoric acid and this product is used to temporarily relieve symptoms of general physical weakness and listlessness, including: fatigue; sore muscles & joints; dry skin; absence of sexual desire; occasional sleeplessness.
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Palliative | PROCALAMINE Approved UseProcalAmine is indicated for peripheral administration in adults to preserve body protein and improve nitrogen balance in well-nourished, mildly catabolic patients who require short-term parenteral nutrition. Launch Date1982 |
|||
Palliative | Unknown Approved UseUnknown |
|||
Palliative | Unknown Approved UseUnknown |
|||
Palliative | Unknown Approved UseUnknown |
|||
Palliative | Unknown Approved UseUnknown |
|||
Diagnostic | Unknown Approved UseUnknown |
|||
Diagnostic | Unknown Approved UseUnknown |
|||
Primary | SODIUM PHOSPHATES INJECTION Approved UseSodium Phosphates Injection, USP, 3mM P/mL, is indicated as a source of phosphorus, for addition to large volume intravenous fluids, to prevent or correct hypophosphatemia in patients with restricted or no oral intake. It is also useful as an additive for preparing specific intravenous fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. The concomitant amount of sodium (4 mEq/mL) must be calculated into total electrolyte content of such prepared solutions. |
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29730
Created by
admin on Fri Dec 15 15:36:45 GMT 2023 , Edited by admin on Fri Dec 15 15:36:45 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
5QWK665956
Created by
admin on Fri Dec 15 15:36:45 GMT 2023 , Edited by admin on Fri Dec 15 15:36:45 GMT 2023
|
PRIMARY | |||
|
314837
Created by
admin on Fri Dec 15 15:36:45 GMT 2023 , Edited by admin on Fri Dec 15 15:36:45 GMT 2023
|
ALTERNATIVE | |||
|
23673460
Created by
admin on Fri Dec 15 15:36:45 GMT 2023 , Edited by admin on Fri Dec 15 15:36:45 GMT 2023
|
PRIMARY | |||
|
C66551
Created by
admin on Fri Dec 15 15:36:45 GMT 2023 , Edited by admin on Fri Dec 15 15:36:45 GMT 2023
|
PRIMARY | |||
|
13472-35-0
Created by
admin on Fri Dec 15 15:36:45 GMT 2023 , Edited by admin on Fri Dec 15 15:36:45 GMT 2023
|
PRIMARY | |||
|
SUB12287MIG
Created by
admin on Fri Dec 15 15:36:45 GMT 2023 , Edited by admin on Fri Dec 15 15:36:45 GMT 2023
|
PRIMARY | |||
|
SUB53031
Created by
admin on Fri Dec 15 15:36:45 GMT 2023 , Edited by admin on Fri Dec 15 15:36:45 GMT 2023
|
PRIMARY | |||
|
100000092043
Created by
admin on Fri Dec 15 15:36:45 GMT 2023 , Edited by admin on Fri Dec 15 15:36:45 GMT 2023
|
PRIMARY | |||
|
1311311
Created by
admin on Fri Dec 15 15:36:45 GMT 2023 , Edited by admin on Fri Dec 15 15:36:45 GMT 2023
|
ALTERNATIVE | RxNorm | ||
|
DBSALT001970
Created by
admin on Fri Dec 15 15:36:45 GMT 2023 , Edited by admin on Fri Dec 15 15:36:45 GMT 2023
|
PRIMARY | |||
|
DTXSID90158903
Created by
admin on Fri Dec 15 15:36:45 GMT 2023 , Edited by admin on Fri Dec 15 15:36:45 GMT 2023
|
PRIMARY | |||
|
1311286
Created by
admin on Fri Dec 15 15:36:45 GMT 2023 , Edited by admin on Fri Dec 15 15:36:45 GMT 2023
|
PRIMARY | |||
|
5QWK665956
Created by
admin on Fri Dec 15 15:36:45 GMT 2023 , Edited by admin on Fri Dec 15 15:36:45 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD